Startups
Scalable and accessible CRISPR technologies. We build intelligent molecular platforms and solutions that deliver scalable, affordable innovations in healthcare, food safety, environmental resilience, and sustainability.
Mentions in press and media 4
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Nov 25, 2025 | Biotech startup CrisprBits raises $3 million to scale its CRISPR platforms for diagnostics and gene editing | Bengaluru-based biotechnology startup CrisprBits Private Limited has raised $3 million through founders, angel investors, family offices at a valuation of $12 million. Advertisment The current pre-Series A funding round was led by Spectrum ... |
| Feb 7, 2024 | CrisprBits' OmiCrisp Tracks Omicron-derived JN.1 Variant in Sewage Samples in Bengaluru | Bengaluru, Karnataka, India The test is currently being used to monitor sewage samples in 14 localities in Bengaluru OmiCrisp is a testing platform for rapid diagnosis and surveillance of SARS-CoV2 Bengaluru-based startup CrisprBits Private... |
| CrisprBits | “Innovating for Human Well-Being” |
Reviews 0
FAQ about CrisprBits
What has the press written about CrisprBits?
Parsers VC has collected 4 articles mentioning CrisprBits, among them “Biotech startup CrisprBits raises $3 million to scale its CRISPR platforms for diagnostics and gene editing” (Nov 25, 2025) and “CrisprBits' OmiCrisp Tracks Omicron-derived JN.1 Variant in Sewage Samples in Bengaluru” (Feb 7, 2024).
Is CrisprBits still active?
Yes, CrisprBits is active; its latest activity on Parsers VC dates from Nov 25, 2025.